LEAD: Toyota to recall Lexus hybrid vehicle over fuel spill concern
Saturday, June 26, 2021 12:15 AM

Related Stories

NEW YORK, Jun. 26, 2010 (Kyodo News International) --

Toyota Motor Corp. announced Friday it will recall the 2010 model of its luxury hybrid Lexus HS 250h sold in the United States over concern that it may cause a fuel spill in a collision.

The automaker said it is working to identify a remedy and will notify owners as soon as one is developed. The recall affects 17,000 units and dealers will not deliver any new vehicles in their inventory until remedied, the automaker said.

The company said it has no plan to withdraw the model in Japan as it meets safety standards.

The HS 250h was put on the U.S. market in August last year. Toyota said there have been no reports of fuel spills in accidents involving the model.

A recent test by the U.S. National Highway Traffic Safety Administration involving striking the vehicle with a barrier from the rear showed fuel spillage exceeding the requirement under a federal vehicle safety standard, Toyota said.

Toyota said its own test under the same protocol during development had found the vehicle to comply with the standard.

The HS 250h, along with its flagship hybrid Prius, was subject to another recall in February due to a defective brake. The latest voluntary recall could adversely impact Toyota's U.S. operations that have been emerging from the unprecedented recall problem.

Toyota has recalled millions of its cars in the United States and other parts of the world since last year over sudden acceleration problems and other defects.

Toyota Motor Kyushu Inc., the Toyota subsidiary producing the HS 250h in Japan, said it will halt production for the North American market for the time being.



Symbol :


Market news:

  • After-Hours Update: DNDN, MSFT, YHOO, AMZN Jun 30, 2021 08:11 PM

    Shares of Dendreon Corporation (NASDAQ: DNDN) plunged more than 17% in late trading after it announced that the Centers for Medicare and Medicaid Services has initiated a National Coverage Analysis of its prostate cancer therapy Provenge to determine "whether or not autologous cellular immunotherapy is reasonable and necessary."

  • ETF Update: TYP, TYH, SPY Jun 30, 2021 07:31 PM

    Direxion Daily Technology Bear 3X Shares (NYSEArca: TYP) was one of the biggest gainer among the ETFs on Wednesday.

  • Earnings Roundup: APOL, SWHC, CBK, SCHN, XRTX Jun 30, 2021 06:44 PM

    Apollo Group, Inc. (NASDAQ: APOL) on Wednesday posted an adjusted quarterly profit that blew past market estimates, helped by double-digit sales growth

  • Stocks Hitting 52-Week Highs: LOOP, NSH, CPNO, MNRO Jun 30, 2021 03:57 PM

    Following is a brief list of stocks touching 52-week highs in intra-day trading on Wednesday, June 30, 2010:

  • Bank of America Surpasses JPMorgan As World's Strongest Bank-Study Jun 30, 2021 03:48 PM

    Bank of America (NYSE: BAC) has surpassed JPMorgan Chase (NYSE: JPM) to rank as the world's top bank in terms of capital strength, according to a new study by the Banker magazine.

More news


    Closest Estimates

User SymbolConsen EPSEstimate EPSActual EPS
Jim OPNT$0.10$0.09$0.07
XXXXX MNT$0.33$0.33$0.35
XXXXX OPNT$0.10$0.05$0.07
XXXXX PETM$0.33$0.33$0.34
XXXXX JBX$0.70$0.82$0.80
XXXXX HPQ$0.69$0.70$0.70
XXXXX OPNT$0.10$0.09$0.07
XXXXX CHUX$0.31$0.35$0.36
XXXXX HPQ$0.69$0.70$0.70
XXXXX CRM$0.01$0.00$0.01

    Recent Estimates

AnalystFirm NameSymbolEPS Estimate
Richard WXXXXX RIMM$1.34
mikeXXXXX RIMM$1.34
joe blowXXXXX DLM$0.22
klineXXXXX Q$0.09
asdasd asd DRYS$0.23